Maxim Group Maintains Buy on Health In Tech, Lowers Price Target to $3
Maxim Group analyst Allen Klee maintains Health In Tech (NASDAQ:HIT) with a Buy and lowers the price target from $4 to $3.
Filings · News reference
Health In Tech Files Prospectus For Resale Of Up To 29,532,889 Shares By Yorkville Under $20M Standby Equity Purchase Agreement
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Health In Tech Q2 2026 Earnings Call: Complete Transcript
Health In Tech (NASDAQ:HIT) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
8-K filing — Health In Tech, Inc. (HIT)
Filed: 2026-08-13 AccNo: 0001213900-26-089249 Size: 268 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits